497
Views
59
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Primary cutaneous B-cell lymphomas – Clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome

, , , &
Pages 1094-1103 | Received 05 Dec 2007, Accepted 18 Mar 2008, Published online: 01 Jul 2009

References

  • Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, LyonFrance 2001
  • Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz J L, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood 1997; 90: 354–371
  • Willemze R, Jaffe E S, Burg G, Cerroni L, Berti E, Swerdlow S H, Ralfkiaer E, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785
  • Burg G, Jaffe E S, Kempf W, Berti E, Cerroni L, Chimenti S, Dummer R, . WHO/EORTC classification of cutaneous lymphomas. P LeBoit, G Burg, D Weedon, A Sarasin, et al. WHO IARC, LyonFrance 2005, WHO Books: Tumors of the Skin
  • Kim Y H, Willemze R, Pimpinelli N, Whittaker S, Olsen E A, Ranki A, Dummer R, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European organization of research and Treatment of cancer (EORTC). Blood 2007; 110: 479–484
  • Senff N J, Willemze R. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Br J Dermatol 2007; 157: 1205–1211
  • Cerroni L, Arzberger E, Pütz B, Höfler G, Metze D, Sander C A, Rose C, et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 2000; 95: 3922–3928
  • Servitje O, Gallardo T, Estrach T, Pujol R M, Blanco A, Fernandez-Sevilla A, Petriz L, et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 2002; 147: 1147–1158
  • Hoefnagel J J, Vermeer M H, Jansen P M, Heule F, Vader P CV, Sanders C JG, Gerritsen M JP, et al. Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases. Arch Dermatol 2005; 141: 1139–1145
  • Goodlad J R, Krajewski A S, Batstone P J, McKay P, White J M, Benton E C, Kavanagh G M, et al. Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am J Surg Pathol 2002; 26: 733–741
  • Senff N J, Hoefnagel J J, Jansen P M, Vermeer M H, van Baarlen J, Blokx W A, Canninga-van Dijk M R, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007; 25: 1581–1587
  • Dummer R, Hassel J C, Fellenberg F, Eichmuller S, Maier T, Slos P, Acres B, et al. Adenovirus-mediated intralesional interferon-gene transfer induces tumor regressions in cutaneous lymphomas. Blood 2004; 104: 1631–1638
  • Cozzio A, Kempf W, Schmid-Meyer R, Gilliet M, Michaelis S, Scharer L, Burg G N, et al. Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma 2006; 47: 865–869
  • Fink-Puches R, Zenahlik P, Bäck B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (EORTC, WHO) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99: 800–805
  • Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457–461
  • Pimpinelli N, Santucci M, Bosi A, Moretti S, Vallecchi C, Messori A, Giannotti B. Primary cutaneous follicular centre-cell lymphoma – a lymphoproliferative disease with favourable prognosis. Clin Exp Dermatol 1989; 14: 12–19
  • Bailey E M, Ferry J A, Harris N L, Mihm M C, Jacobson J O, Duncan L M. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients. Am J Surg Pathol 1996; 20: 1011–1023
  • Rijlaarsdam J U, Toonstra J, Meijer O W, Noordijk E M, Willemze R. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol 1996; 14: 549–555
  • Cerroni L, Signoretti S, Hofler G, Annessi G, Putz B, Lackinger E, Metze D, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997; 21: 1307–1315
  • Grange F, Bekkenk M W, Wechsler J, Meijer C JLM, Cerroni L, Bernengo M, Bosq J, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study. J Clin Oncol 2001; 19: 3602–3610
  • Goodlad J R, Krajewski A S, Batstone P J, McKay P, White J M, Benton E C, Kavanagh G M, Lucraft H H. Primary cutaneous diffuse large B-cell lymphoma. Prognostic significance and clinicopathologic subtypes. Am J Surg Pathol 2003; 27: 1538–1545
  • Kodama K, Massone C, Chott A, Metze D, Kerl H, Cerroni L. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005; 106: 2491–2497
  • Hembury T A, Lee B, Gascoyne R D, Macpherson N, Yang B, House N, Medeiros L J, Hsi E D. Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases. Am J Clin Pathol 2002; 117: 574–580

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.